CDRE's Quality Score fell 2 points on Tue, Nov 3, to 4. Its price fell below its falling average of the last 200 days. 2 more reasons, for Pro members.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 15% over three years while the S&P 500 rose 81%.
| Holding it back | Below a falling 200-day average |
| Latest filing | 10-Q, Aug 5 |
ReportReports today, after the close. Every 3 months, a company tells everyone how much it sold and earned. It rose after 2 and fell after 2 of its last 4 reports, -1.0% on average. Past reports ›
Thu Nov 5: Q3 2026 Earnings Conference CallDate confirmed.
After its last 4 reports it closed -1.0% on average, higher 2 of 4 times.
Below Averagefor quality, not price, 5 of 14 chart checks firingWhat the Quality Score means
CDRE is #44 of 85 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 44 |
Reports Wed Nov 4, after the close (today). Confirmed.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
“The decrease was primarily a result of increased contingent consideration expense, compensation expense and adverse foreign currency fluctuations, partially offset by increased gross profit.”
CDRE's results filing gives no sales by line in a table we read.
| Measure | Figure |
|---|---|
| Net sales | $749M to $769M |
“Gross profit margin was 42.1% for the quarter ended June 30, 2026, as compared to 40.9% for the quarter ended June 30, 2025, mainly driven by favorable pricing, partially offset by an increase in inventory step-up amortization.”
From its results filing (SEC filing · Aug 5)
Sales grew 8.6% a year over 5 years, fiscal 2020 to 2025.
Pays $0.40 a share a year.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 5, 2026 | +11.5% | +12.9% | +8.7% |
| May 11, 2026 | -13.2% | -9.5% | -6.7% |
| Mar 10, 2026 | -7.8% | -13.5% | -18.9% |
Sales grew every year from 2020 to 2025, to $610M. It made a profit in each of the six years.
Its dividends come to 22% of its free cash flow.
| Dividend | $0.40 a share a year |
| Paid out | About $17.1M a year |
| Free cash flow | $78.1M |
| Record | Raised each of the last 3 years |
2 insiders sold $18.1M across 11 filings in the last 6 months. No open-market buys on record. The newest:
One trade disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: CDRE is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments - the Product segment, which is comprised of components that manufacture and sell products, and the Distribution segment, which is comprised of business that serves as a one-stop shop for law enforcement agencies that sells goods produced by the Product segment, as well as other third-party products.
“We compete in the large public safety and outdoor and recreation markets amongst other ancillary addressable markets.”
CDRE scores 4 today, which Breakaway calls Below Average. It is #44 of 85 in Medical Devices by Quality Score, with 5 of 14 chart checks firing. Up 15% over three years while the S&P 500 rose 81%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
CDRE scores 4 today, which Breakaway calls Below Average (0 to 5). That is #44 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind CDRE's 4.
2 insiders sold $18.1M across 11 filings in the last 6 months. No open-market buys on record. The newest is Warren B. Kanders, CEO and Chairman, who sold $2.2M on Aug 24. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.